Neurofeedback has been used in clinical practice for many years. At the same time, there is ongoing discussion about the neurophysiological mechanisms through which different neurofeedback approaches exert their effects. In the case of Infra-Low Frequency (ILF) neurofeedback in particular, imaging studies demonstrating objective changes in the brain beyond subjective reports have so far been limited.
A study published in December 2025 in the scientific journal NeuroImage addresses this gap. The aim of the work was not to evaluate the clinical efficacy of neurofeedback, but to investigate the neurophysiological effects of the signal components of an established ILF neurofeedback protocol from a mechanistic perspective.

Meet The CJ3 Foundation from Albia, Iowa!

The CJ3 Foundation, founded by veteran Eric D. Thomas, is a 501(c)(3) nonprofit public charity dedicated to “Serving Our Nation’s Wounded Heroes.” CJ3 provides vital support, services, and advocacy for wounded and disabled U.S. Military Service Members, Veterans, Law Enforcement Officers, Firefighters, and Emergency/First Responders. Their mission is to help America’s heroes find the means and opportunities to holistically improve their quality of life and reconnect with the communities they so selflessly served.

We are delighted to share some exciting news with the neurofeedback community: the Annual Conference for Applied Neurofeedback (ACAN) is returning for its fourth edition, taking place June 6–8, 2026, in Opatija, Croatia.

Each year, ACAN brings together experts, researchers, and practitioners from around the globe to exchange knowledge, showcase new work, and discuss the evolving landscape of applied neurofeedback.

A recently published study by Theis et al. (2025) examines the effectiveness of ILF Neurofeedback across different diagnostic groups and explores whether subjective symptom changes correlate with objective performance measures.